RecruitingNCT05524090

PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Studying Best vitelliform macular dystrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Principal Investigator
Marc G Besselink, MD, MSc, PhD
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Intervention
Implementation - International best-practice care(other)
Enrollment
223 target
Eligibility
18 years · All sexes
Timeline
2021 – 2030

Study locations (1)

Collaborators

UMC Utrecht · Erasmus Medical Center · Leiden University Medical Center · University Medical Center Groningen · Radboud University Medical Center · Maastricht University Medical Center · Medisch Spectrum Twente · Isala · Frisius Medisch Centrum · Onze Lieve Vrouwe Gasthuis · Amphia ziekenhuis · Jeroen Bosch Ziekenhuis · Catharina Ziekenhuis Eindhoven · University of Colorado, Denver · Heidelberg University · M.D. Anderson Cancer Center · NYU Langone Health · Dutch Cancer Society · Maag Lever Darm Stichting · Deltaplan Alvleesklierkanker

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05524090 on ClinicalTrials.gov

Other trials for Best vitelliform macular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Best vitelliform macular dystrophy →

← Back to all trials